series-b
Stage
1
Investors
About
Santa Ana Bio develops engineered antibody therapies that precisely target immune cell pathways to treat autoimmune and inflammatory diseases.
Explore Santa Ana Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.